Open AccessA vascular smooth muscle‐specific CD4 + T cell line that induces pulmonary vasculitis in MRL‐+/+ mice
Author(s) -
SUMITA S.,
OZAKI S.,
OKAZAKI T.,
SOBAJIMA J.,
NAKAO K.
Publication year - 1996
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1046/j.1365-2249.1996.d01-737.x
Subject(s) - immunology , antigen , biology , adoptive cell transfer , t cell , epitope , microbiology and biotechnology , immune system
We established a T cell line, MV1, specific for rat vascular smooth muscle antigen from the regional lymph nodes of immunized MRL/Mp‐+/+ mice. Adoptive transfer of MV1 T cells induced vasculitis lesions in the lungs of the syngeneic recipient mice pre‐treated with cyclophosphamide. Flow cytometric analysis showed that MV1 was a CD4 + T cell line. The T cells proliferated in the presence of the vascular smooth muscle antigen and mitomycin C‐treated syngeneic spleen cells. The cross experiments using an ovalbumin‐specific T cell line demonstrated that MV1 was specific for vascular smooth muscle antigen. The antigen‐specific proliferation of MV1 was CD4‐dependent, which was consistent with the flow cytometric analysis. In addition, MV1 T cells, upon activation with anti‐CD3 antibody or antigen‐specific activation, killed A20.2J mouse B lymphoma cells. MV1 T cells also killed a CD95 (Fas)‐transfected T lymphoma line, but not its parental Fas‐negative cell line. These findings indicate that MV1 T cells killed target cells via a Fas ligand (FasL)/Fas pathway. The cytotoxicity of MV1 T cells may play an important role in the development of vasculitis in this model. Although the antigenic epitopes of MV1 and the lung specificity of vasculitis remain to be clarified, MV1‐induced vasculitis should serve as an experimental model of human pulmonary vasculitis.